Skip to main content
Screener/Healthcare/Biotechnology

ESPR — Esperion Therapeutics, Inc.

NASDAQ
$3.15+0.01 (+0.16%)
Small CapPenny StockUnder $5Healthcare
$0.95
$4.17
$3.15
$3.16
EPS (TTM)$-0.06
P/E Ratio-19.93
Dividend Yield—
Market Cap$654.9M
Volume4.79M
Prev Close$3.15
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$80.1M-$25.2M$-0.1056.8%-31.5%
Q4 '25$168.4M$61.8M$0.2283.5%36.7%
Q3 '25$87.3M-$31.3M$-0.1636.5%-35.9%
Q2 '25$82.4M-$12.7M$-0.0265.4%-15.4%
Q1 '25$65.0M-$40.5M$-0.2151.5%-62.2%
Q4 '24$69.1M-$21.3M$-0.1162.9%-30.8%
Q3 '24$51.6M-$29.5M$-0.1566.5%-57.2%
Q2 '24$73.8M-$61.9M$-0.3378.9%-83.9%
Get Your Daily Market Recap